Cytokines and other immunological parameters as markers of distant organ involvement in acute pancreatitis;Citocinas y otros parámetros inmunológicos como marcadores de alteración de órganos a distancia en la pancreatitis aguda

Medicina Clinica

Volumn 128, Issue 11, 2007, Pages 401-406

  Martín Alonso, María Ángeles ^a,c   Santamaría, Ana ^a   Saracíbar, Esther ^a   Arranz, Eduardo ^b   Garrote, José Antonio ^b   Almaraz, Ana ^c   Caro Patón, Agustín ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Acute pancreatitis; Cytokines; ICAM 1

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACUTE PANCREATITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LIVER FUNCTION; OXYGEN TENSION;

EID: 34247477297     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13100335     Document Type: Article

References (30)

1. Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 1997;92:377-86.
2. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998; 175:76-83.
3. Saluja AK, Steer ML. Pathophysiology of pancreatitis. Digestion. 1999;60 Suppl 1:27-33.
4. Bockman DE. Toward understanding pancreatic disease: from architecture to cell signaling. Pancreas. 1995;11:324-9.
5. Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y. Immune function in patients with acute pancreatitis. J Gastroenterol Hepatol. 2003; 18: 363-70.
6. Sweeney KJ, Coates C, Murphy T, Reynolds JV. Serum antigen(s) drive the proinflammatory T cell response in acute pancreatitis. Br J Surg. 2003;90: Z313-9.
7. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202: 145-56.
8. Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs. 2001;2: 496-501.
9. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta. 2002;1592:323-43.
10. Lebel-Binay S, Berger A, Zinzindohoue F, Cugnenc P, Thiounn N, Fridman WH, et al. Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw. 2000;11:15-26.
11. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med. 2002; 80:147-62.
12. Mozo G, Del Olmo ML, Caro-Patón A, Reyes E, Manzano L, Belmonte A, et al. Afectación pulmonar y níveles de citocinas en un modelo de pancreatitis aguda experimental. Rev Esp Enferm Dig. 2002;94:53-9.
13. Rau B, Baumgart K, Paszkowski AS, Mayer JM, Beger HG. Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complication. Crit Care Med. 2001;29:1556-62.
14. Frossard JL, Saluja A, Bhagat L, Lee HS, Bhatia M, Hofbauer B, et al. The role of intracellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology. 1999;116:694-701.
15. Werner J, Z'graggen K, Fernández-del Castillo C, Lewandrowski KB, Compton CC, Warshaw A. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM1. Ann Surg. 1999;226:834-42.
16. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg. 1993;128: 586-90.
17. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, et al. Diagnosis, objective assessment of severity and management of acute pancreatitis. The Santorini Consensus Conference. Int J Pancreatol. 1999;25:195-210.
18. Liu Z, Diehl AM. Innate Immunity in the liver. Curr Opin Gastroenterol. 2003;19:565-71.
19. Seki S, Habu Y, Kawamura T, Takada K, Dobashi H, Ohkama T, et al. The liver as a crucial organ in the first line of host defense: the role of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells and T helper 1 immune responses. Immunol Rev. 2000;174:35-46.
20. Sewnath ME, Van der Poll T, Cornells JF, Van Noorden T, Ten Take F, Gouma DJ. Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation. Am J Respir Crit Care. 2004;169:413-20.
21. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumour necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology. 1992;15:1132-6.
22. Akiyama T, Hasegawa T, Sejima T, Sahara H, Seto K, Saito H, et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology. 1998;45:665-71.
23. Liu Z, Sakamoto T, Yokomuro S, Ezure T, Subbotin V, Murase N, et al. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver. 2000;20:114-24.
24. Shimoda K, Begum NA, Shibuta K, Mori M, Bonkovsky HL, Banner BF. Interleukin-8 and hIRH (SDFI-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology. 1998;28:108-15.
25. Fernández de Sousa A, García Monzón C. Papel de las quimiocinas en la patogenia de las enfermedades hepáticas. Rev Esp Enferm Dig. 2003;95:607-13.
26. El-Sayed IH, El Kady IM, Badra GA. The effect of endoscopic cholangiopancreatography on serum IL-18 and erythrocytes antioxidative capacity in biliary obstructive jaundice. Clin Chim Acta. 2003; 336:123-8.
27. Arend WP, Malyak M, Guthiridge GJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunology. 1998;16:27-55.
28. Marti L, Moreno A, Filella X, Marín JL, Almela M, Benito N, et al. Vaior de las citocinas proinflamatorias como factor de predicción de sepsis y mortalidad en el anciano con fiebre. Med Clin (Barc). 2003;121:361-6.
29. Lundberg AH, Granger N, Russell J, Callicutt S, Gaber LW, Kotb M, et al. Temporal correlation of tumour necrosis factor-alpha release, upregulation of pulmonary ICAM-1, and VCAM-1, neutrophil sequestration, and lung injury in diet induced pancreatitis. J Gastrointest Surg. 2000; 4:248-57.
30. Werner J, Hartwing W, Uhl W, Müller C, Ñuchler W. Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology. 2003;3:115-27.